TNFSF10 and cancer: Furthermore, the crosstalk signals between cancer cells and stromal cells may help to predict the responses of cancer microenvironment to TRAIL-sensitive cancer cells and even identify patient groups that will receive the greatest benefits from TRAIL or IFN-β-based therapies.